期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Pathological,molecular,and clinical characteristics of cholangiocarcinoma:A comprehensive review 被引量:7
1
作者 Mukul Vij Yogesh Puri +4 位作者 Ashwin Rammohan Gowripriya G Rajesh Rajalingam ilankumaran kaliamoorthy Mohamed Rela 《World Journal of Gastrointestinal Oncology》 SCIE 2022年第3期607-627,共21页
Cholangiocarcinomas are a heterogeneous group of highly aggressive cancers that may arise anywhere within the biliary tree.There is a wide geographical variation with regards to its incidence,and risk-factor associati... Cholangiocarcinomas are a heterogeneous group of highly aggressive cancers that may arise anywhere within the biliary tree.There is a wide geographical variation with regards to its incidence,and risk-factor associations which may include liver fluke infection,primary sclerosing cholangitis,and hepatolithiasis amongst others.These tumours are classified into intrahepatic,perihilar and distal based on their anatomical location.Morphologically,intrahepatic cholangiocarcinomas are further sub-classified into small and large duct variants.Perihilar and distal cholangiocarcinomas are usually mucin-producing tubular adenocarcinomas.Cholangiocarcinomas develop through a multistep carcinogenesis and are preceded by dysplastic and in situ lesions.While clinical characteristics and management of these tumours have been extensively elucidated in literature,their ultra-structure and tumour biology remain relatively unknown.This review focuses on the current knowledge of pathological characteristics,molecular alterations of cholangiocarcinoma,and its precursor lesions(including biliary intraepithelial neoplasia,intraductal papillary neoplasms of the bile duct,intraductal tubulopapillary neoplasms and mucinous cystic neoplasm). 展开更多
关键词 CHOLANGIOCARCINOMA Classification PATHOLOGY Molecular features Precursors lesions Treatment
下载PDF
Pediatric metabolic liver diseases:Evolving role of liver transplantation 被引量:1
2
作者 Jagadeesh Menon Mukul Vij +4 位作者 Deepti Sachan Ashwin Rammohan Naresh Shanmugam ilankumaran kaliamoorthy Mohamed Rela 《World Journal of Transplantation》 2021年第6期161-179,共19页
Metabolic liver diseases(MLD)are the second most common indication for liver transplantation(LT)in children.This is based on the fact that the majority of enzymes involved in various metabolic pathways are present wit... Metabolic liver diseases(MLD)are the second most common indication for liver transplantation(LT)in children.This is based on the fact that the majority of enzymes involved in various metabolic pathways are present within the liver and LT can cure or at least control the disease manifestation.LT is also performed in metabolic disorders for end-stage liver disease,its sequelae including hepatocellular cancer.It is also performed for preventing metabolic crisis’,arresting progression of neurological dysfunction with a potential to reverse symptoms in some cases and for preventing damage to end organs like kidneys as in the case of primary hyperoxalosis and methyl malonic acidemia.Pathological findings in explant liver with patients with metabolic disease include unremarkable liver to steatosis,cholestasis,inflammation,variable amount of fibrosis,and cirrhosis.The outcome of LT in metabolic disorders is excellent except for patients with mitochondrial disorders where significant extrahepatic involvement leads to poor outcomes and hence considered a contraindication for LT.A major advantage of LT is that in the post-operative period most patients can discontinue the special formula which they were having prior to the transplant and this increases their well-being and improves growth parameters.Auxiliary partial orthotopic LT has been described for patients with noncirrhotic MLD where a segmental graft is implanted in an orthotopic position after partial resection of the native liver.The retained native liver can be the potential target for future gene therapy when it becomes a clinical reality. 展开更多
关键词 Liver transplantation Metabolic liver disease TYROSINEMIA Wilson disease Glycogen storage diseases Urea cycle disorders PATHOLOGY Auxiliary liver transplant
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部